The cosmetics heavyweight expands its business. The group has just announced its investment in MiYé, a brand specializing in balancing women’s hormonal well-being. The aim is to enable the young company to accelerate its development by benefiting from the medical expertise of Pierre Fabre Laboratories and their knowledge of the pharmacy channel.
Co-founded by Caroline de Blignières and Anna Oualid, MiYé is positioned in the hormonal well-being segment. The brand offers a range of 13 products (five dietary supplements and eight dermocosmetics).
“Pierre Fabre Laboratories’ acquisition of a stake in MiYé two years after our market launch is a tremendous recognition. It’s an invaluable opportunity to strengthen our R&D resources so that we can promote the democratization of women’s hormonal health and redefine together the rules of a new ecology for the female body, one that is holistic, transgenerational and above all safer,” declared Caroline de Blignières.
This financial support will enable MiYé to accelerate its R&D investments, carry out clinical studies, reinforce the scientific and medical backing of its flagship products, and continue its development in the pharmacy channel.
